PMC:7408073 / 37010-37282
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T221","span":{"begin":111,"end":122},"obj":"Body_part"},{"id":"T222","span":{"begin":129,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A221","pred":"fma_id","subj":"T221","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A222","pred":"fma_id","subj":"T222","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1456","span":{"begin":196,"end":202},"obj":"Gene"},{"id":"1457","span":{"begin":57,"end":63},"obj":"Gene"},{"id":"1464","span":{"begin":65,"end":77},"obj":"Disease"}],"attributes":[{"id":"A1456","pred":"tao:has_database_id","subj":"1456","obj":"Gene:24179"},{"id":"A1457","pred":"tao:has_database_id","subj":"1457","obj":"Gene:24179"},{"id":"A1464","pred":"tao:has_database_id","subj":"1464","obj":"MESH:D007674"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T230","span":{"begin":71,"end":77},"obj":"Disease"}],"attributes":[{"id":"A230","pred":"mondo_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/MONDO_0021178"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T434","span":{"begin":31,"end":32},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T435","span":{"begin":127,"end":134},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T436","span":{"begin":221,"end":222},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T437","span":{"begin":235,"end":236},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T336","span":{"begin":57,"end":60},"obj":"Chemical"},{"id":"T337","span":{"begin":61,"end":63},"obj":"Chemical"},{"id":"T338","span":{"begin":196,"end":199},"obj":"Chemical"},{"id":"T339","span":{"begin":200,"end":202},"obj":"Chemical"},{"id":"T340","span":{"begin":241,"end":245},"obj":"Chemical"}],"attributes":[{"id":"A336","pred":"chebi_id","subj":"T336","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A337","pred":"chebi_id","subj":"T337","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A338","pred":"chebi_id","subj":"T338","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A339","pred":"chebi_id","subj":"T339","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"id":"A340","pred":"chebi_id","subj":"T340","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T173","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}
2_test
{"project":"2_test","denotations":[{"id":"32708755-20713916-20678754","span":{"begin":268,"end":270},"obj":"20713916"}],"text":"Moreover, in SHRs treated with A-779 in combination with Ang II, renal injury and interstitial infiltration of macrophages and T cells were surprisingly reduced as compared with SHRs treated with Ang II alone, suggesting a safe use of A-779 drug in in vivo infusions [83]."}